Close search
Scientific papers

Scientific papers

Favorite Articles

    Tags

    Categories

    Authors

    result
    Date
    Unveiling Swelling and Erosion Dynamics: Early Development Screening of Mirabegron Extended Release Tablets

    Unveiling Swelling and Erosion Dynamics: Early Development Screening of Mirabegron Extended Release Tablets

    Papers - 27/11/2024 - by Ana S. Sousa, J. Serra, C. Estevens, R. Costa, António J. Ribeiro
    The development of extended-release (ER) matrices has been widely studied, yet identifying the optimal drug release mechanism to achieve target release profiles remains a resource-intensive challenge in early formulation stages. …
    Mannitol-coated hydroxypropyl methylcellulose as an alternative directly compressible

    Mannitol-coated hydroxypropyl methylcellulose as an alternative directly compressible controlled release excipient

    Newsfeeds - 28/08/2024 -
    One of the most common forms of controlled release technology for oral drug delivery involves dispersing an active ingredient in a hydrophilic matrix-forming polymer like hydroxypropyl methylcellulose (HPMC), which is …
    Tablet_TabInTab_5

    How To achieve different release profiles and select excipients for formulation development of modified release oral solid dosage forms

    Newsfeeds - 10/07/2024 -
    Modified release oral solid dosage forms (MROSD) are specialized formulations that enable drug release over a defined period or at specific GI tract locations, improving patient adherence and reducing side …
    Tablet_Minitablet_vs_tablet_1

    Development of mini-tablet and multi-unit pellet systems (MUPs)

    Newsfeeds - 24/05/2024 -
    The text discusses the development and benefits of Mini-Tablet and Multi-Unit Pellet Systems (MUPS) in oral drug delivery. These advanced dosage forms offer controlled and sustained release profiles, achieved through …
    New Hydrophilic Matrix Tablets for the Controlled Released of Chlorzoxazone

    New hydrophilic matrix tablets for the controlled released of chlorzoxazone

    Papers - 09/05/2024 - by Andreea Creteanu, Gabriela Lisa, Cornelia Vasile, Maria-Cristina Popescu, Daniela Pamfil, Claudiu N. Lungu, Alina Diana Panainte, Gladiola Tantaru
    The controlled release of active ingredients like chlorzoxazone from matrix tablets, utilizing Kollidon®SR and chitosan, relies on both the drug's solubility in the dissolution medium and the composition of the …
    image twin screw granulation process

    A QbD guided development of a Twin-Screw Granulation process

    Newsfeeds - 12/03/2024 -
    The text discusses dry granulation techniques in the pharmaceutical industry, focusing on roller compaction and slugging, highlighting their limitations such as inferior tablet strength and reduced yield due to fine …
    White powder heap

    MEGGLE highlights role of excipient properties in alcohol-induced dose dumping AIDD

    Newsfeeds - 01/03/2024 -
    The white paper from MEGGLE emphasizes the significance of excipients in addressing alcohol-induced dose dumping (AIDD) in modified-release tablet formulations. AIDD occurs when drugs prematurely release into the bloodstream due …
    Studying the API Distribution of Controlled Release Formulations Produced via Continuous Twin-Screw Wet Granulation: Influence of Matrix Former, Filler and Process Parameters

    Studying the API distribution of controlled release formulations produced via continuous twin-screw wet granulation: influence of matrix former, filler and process parameters

    Papers - 28/02/2024 - by Phaedra Denduyver, Chris Vervaet, Valérie Vanhoorne
    Hydroxypropyl methylcellulose (HPMC) stands out as the favored hydrophilic matrix former in the production of controlled release formulations via continuous twin-screw wet granulation. However, previous observations have highlighted a challenge: …
    Tablet_Multilayer_15_HD.original

    Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products

    Newsfeeds - 20/02/2024 -
    This retrospective study, spanning from 2001 to 2021, examined submissions approved by the US Food and Drug Administration (FDA) for Modified Release (MR) orally administered drugs [Extended-Release (ER) and Delayed-Release …
    Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation

    Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation

    Papers - 21/11/2023 - by Ji Yeon Kim, Tae Hwan Kim, Eunbin Kim, Du Hyung Choi
    Objective: This study aimed to devise a developmental strategy for matrix tablets containing mirabegron, incorporating a quality by design approach that considers geometric properties such as gel strength, erosion rate, …
    no-image

    Evaluation of in-die compression data for a deeper understanding of altered excipient properties upon temperature rise

    Papers - 28/03/2023 - by Hanna Dorothea Grumann, Stefan Klinken, Peter Kleinebudde
    The thermodynamic analysis of tablet formation involves assessing both thermal and mechanical aspects during compression. This study aimed to examine variations in force–displacement data resulting from temperature increases, serving as …
    Poly(2-alkyl-2-oxazoline)s: A polymer platform to sustain the release from tablets with a high drug loading

    Poly(2-alkyl-2-oxazoline)s: A polymer platform to sustain the release from tablets with a high drug loading

    Papers - 01/12/2022 - by Aseel Samaro, Maarten Vergaelen, Martin Purino, Ali Tigrine, Victor R. de la Rosa, Niloofar Moazami Goudarzi, Matthieu N. Boone, Valérie Vanhoorne, Richard Hoogenboom, Chris Vervaet
    Achieving sustained release of highly dosed active pharmaceutical ingredients (APIs) from a matrix tablet poses a significant challenge. To tackle this issue, this study assessed the efficacy of thermoplastic poly(2-alkyl-2-oxazoline)s …
    Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor

    Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor

    Papers - 05/03/2022 - by Qiangnan Zhang, Thomas Durig, Benjamin Blass, Reza Fassihi
    Apremilast, a selective PDE4 inhibitor approved for various inflammatory disorders, is categorized as a BCS-IV drug and exists in seven polymorphic forms. This study outlines the creation of a sustained-release …
    Starch-based controlled release matrix tablets: impact of the type of starch

    Starch-based controlled release matrix tablets: impact of the type of starch

    Papers - 20/10/2020 - by D. Elgaied-Lamouchi, N. Descamps, P. Lefevre, I. Rambur, J.-Y. Pierquin, F. Siepmann, J. Siepmann, S. Muschert
    Various starch types were employed in the formulation of controlled release tablets containing diprophylline through direct compression. The study explored the influence of starch's natural origin, potential chemical modifications (such …
    Robustness of controlled release tablets based on a cross-linked pregelatinized potato starch matrix

    Robustness of controlled release tablets based on a cross-linked pregelatinized potato starch matrix

    Papers - 01/07/2020 - by D. Elgaied-Lamouchi, N. Descamps, P. Lefèvre, A. R. Mackin-Mohamour, C. Neut, F. Siepmann, Juergen Siepmann, S. Muschert
    The objective of this research was to assess the viability of utilizing cross-linked pregelatinized potato starch (marketed as PREGEFLO ® PI10) as a matrix former for controlled release tablets. Various …
    A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets

    A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets

    Papers - 01/01/2020 - by Tze Ning Hiew, Yu Harn Tian, Huei Ming Tan, Paul Wan Sia Heng
    The potential harm to the drug diffusion coat barrier of controlled-release pellets due to compaction force during the preparation of multiple-unit pellet system tablets is a significant concern. Prior research …
    no-image

    STYL’One Evolution / Industrial rotary press correlation study on a tab-in-tab dosage form

    Bulletins - 01/02/2018 - by Aline Moulin
    These case studies were presented by SKYEPHARMA during CSF Cambridge 2018 to highlight the development of multilayer and tab-in-tab dosage forms on STYL’One Evo while saving time and cost during …
    Amorphous-based controlled-release gliclazide matrix system

    Amorphous-based controlled-release gliclazide matrix system

    Papers - 01/07/2017 - by Zheng Lu, Yonglai Yang, Rae-Ann Covington, Yunxia Bi, Thomas Dürig, Reza Fassihi
    The objective of this study was to create a hydrophilic oral controlled release system (CRS) utilizing the amorphous form of gliclazide, a BCS class II compound listed in the WHO …
    no-image

    Novel polyurethane matrix systems reveal a particular sustained release behavior studied by imaging and computational modeling

    Papers - 01/07/2017 - by María Dolores Campiñez, Isidoro Caraballo, Maxim Puchkov, Martin Kuentz
    The objective of this study was to enhance the comprehension of the drug-release mechanism from sustained release matrices utilizing two recently developed polyurethanes. A novel in silico formulation tool based …
    Supersaturated controlled release matrix using amorphous dispersions of glipizide

    Supersaturated controlled release matrix using amorphous dispersions of glipizide

    Papers - 01/09/2016 - by Zheng Lu, Yonglai Yang, Rae-Ann Covington, Yunxia (Vivian) Bi, Thomas Dürig, Marc A. Ilies, Reza Fassihi
    Spray-dried dispersions (SDDs) of glipizide, a model drug classified as BCS Class II, were created utilizing various hydroxypropyl methylcellulose acetate succinate (HPMCAS) grades and copovidone S-630 as carriers. Analysis through …
    no-image

    Production of extended release mini-tablets using directly compressible grades of HPMC

    Papers - 01/11/2013 - by Faiezah A. A. Mohamed, Matthew Roberts, Linda Seton, James L. Ford, Marina Levina, Ali R. Rajabi-Siahboomi
    Background: Hypromellose (HPMC) has been utilized previously to regulate drug release in mini-tablets. However, due to suboptimal flow characteristics, the production of mini-tablets with elevated HPMC levels presents a challenge. …